BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scott L Jr, Fender AC, Saljic A, Li L, Chen X, Wang X, Linz D, Lang J, Hohl M, Twomey D, Pham TT, Diaz-Lankenau R, Chelu MG, Kamler M, Entman ML, Taffet GE, Sanders P, Dobrev D, Li N. NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias. Cardiovasc Res 2021;117:1746-59. [PMID: 33523143 DOI: 10.1093/cvr/cvab024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Gawałko M, Saljic A, Li N, Abu-Taha I, Jespersen T, Linz D, Nattel S, Heijman J, Fender A, Dobrev D. Adiposity-associated atrial fibrillation: molecular determinants, mechanisms and clinical significance. Cardiovasc Res 2022:cvac093. [PMID: 35689487 DOI: 10.1093/cvr/cvac093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Papadopoulos PD, Tsigalou C, Valsamaki PN, Konstantinidis TG, Voidarou C, Bezirtzoglou E. The Emerging Role of the Gut Microbiome in Cardiovascular Disease: Current Knowledge and Perspectives. Biomedicines 2022;10:948. [DOI: 10.3390/biomedicines10050948] [Reference Citation Analysis]
3 Yarmohammadi F, Hayes AW, Karimi G. Possible protective effect of resolvin D1 on inflammation in atrial fibrillation: involvement of ER stress mediated the NLRP3 inflammasome pathway. Naunyn Schmiedebergs Arch Pharmacol 2021;394:1613-9. [PMID: 34216224 DOI: 10.1007/s00210-021-02115-0] [Reference Citation Analysis]
4 Krishnan A, Sharma H, Yuan D, Trollope AF, Chilton L. The Role of Epicardial Adipose Tissue in the Development of Atrial Fibrillation, Coronary Artery Disease and Chronic Heart Failure in the Context of Obesity and Type 2 Diabetes Mellitus: A Narrative Review. JCDD 2022;9:217. [DOI: 10.3390/jcdd9070217] [Reference Citation Analysis]
5 Kong F, You H, Zheng K, Tang R, Zheng C. The crosstalk between pattern-recognition receptor signaling and calcium signaling. Int J Biol Macromol 2021;192:745-56. [PMID: 34634335 DOI: 10.1016/j.ijbiomac.2021.10.014] [Reference Citation Analysis]
6 Nattel S, Sager PT, Hüser J, Heijman J, Dobrev D. Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it. Cardiovasc Res 2021;117:1616-31. [PMID: 33769493 DOI: 10.1093/cvr/cvab093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ajoolabady A, Nattel S, Lip GY, Ren J. Inflammasome Signaling in Atrial Fibrillation. Journal of the American College of Cardiology 2022;79:2349-66. [DOI: 10.1016/j.jacc.2022.03.379] [Reference Citation Analysis]
8 Fender AC, Gawalko M, Dobrev D. Direct oral anticoagulation and severe obesity - One size fits all? Int J Cardiol Heart Vasc 2021;37:100923. [PMID: 34934804 DOI: 10.1016/j.ijcha.2021.100923] [Reference Citation Analysis]
9 Ge C, Zhao Y, Liang Y, He Y, Sun Y. Silencing of TLR4 Inhibits Atrial Fibrosis and Susceptibility to Atrial Fibrillation via Downregulation of NLRP3-TGF-β in Spontaneously Hypertensive Rats. Disease Markers 2022;2022:1-16. [DOI: 10.1155/2022/2466150] [Reference Citation Analysis]
10 Fan J, Ren M, Adhikari BK, Wang H, He Y. The NLRP3 Inflammasome as a Novel Therapeutic Target for Cardiac Fibrosis. J Inflamm Res 2022;15:3847-58. [PMID: 35836721 DOI: 10.2147/JIR.S370483] [Reference Citation Analysis]
11 Andelova K, Bacova BS, Sykora M, Hlivak P, Barancik M, Tribulova N. Mechanisms Underlying Antiarrhythmic Properties of Cardioprotective Agents Impacting Inflammation and Oxidative Stress. Int J Mol Sci 2022;23:1416. [PMID: 35163340 DOI: 10.3390/ijms23031416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Zuo K, Fang C, Liu Z, Fu Y, Liu Y, Liu L, Wang Y, Yin X, Liu X, Li J, Zhong J, Chen M, Xu L, Yang X. Commensal microbe-derived SCFA alleviates atrial fibrillation via GPR43/NLRP3 signaling. Int J Biol Sci 2022;18:4219-32. [PMID: 35844801 DOI: 10.7150/ijbs.70644] [Reference Citation Analysis]
13 Gawałko M, Agbaedeng TA, Saljic A, Müller DN, Wilck N, Schnabel R, Penders J, Rienstra M, van Gelder I, Jespersen T, Schotten U, Crijns HJGM, Kalman JM, Sanders P, Nattel S, Dobrev D, Linz D. Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications. Cardiovasc Res 2021:cvab292. [PMID: 34550344 DOI: 10.1093/cvr/cvab292] [Reference Citation Analysis]
14 Linz D, Gawałko M, Sanders P, Penders J, Li N, Nattel S, Dobrev D. Does gut microbiota affect atrial rhythm? Causalities and speculations. Eur Heart J 2021:ehab467. [PMID: 34338744 DOI: 10.1093/eurheartj/ehab467] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Saljic A, Heijman J, Dobrev D. Emerging Antiarrhythmic Drugs for Atrial Fibrillation. Int J Mol Sci 2022;23:4096. [PMID: 35456912 DOI: 10.3390/ijms23084096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Hiram R. Cardiac cytokine therapy? Relevance of targeting inflammatory mediators to combat cardiac arrhythmogenic remodeling. Int J Cardiol Heart Vasc 2021;37:100918. [PMID: 34849391 DOI: 10.1016/j.ijcha.2021.100918] [Reference Citation Analysis]
17 Li P, Kurata Y, Taufiq F, Kuwabara M, Ninomiya H, Higaki K, Tsuneto M, Shirayoshi Y, Lanaspa MA, Hisatome I. Kv1.5 channel mediates monosodium urate-induced activation of NLRP3 inflammasome in macrophages and arrhythmogenic effects of urate on cardiomyocytes. Mol Biol Rep. [DOI: 10.1007/s11033-022-07378-1] [Reference Citation Analysis]
18 Young LJ, Antwi-Boasiako S, Ferrall J, Wold LE, Mohler PJ, El Refaey M. Genetic and non-genetic risk factors associated with atrial fibrillation. Life Sci 2022;299:120529. [PMID: 35385795 DOI: 10.1016/j.lfs.2022.120529] [Reference Citation Analysis]
19 Wang F, Liang Q, Ma Y, Sun M, Li T, Lin L, Sun Z, Duan J. Silica nanoparticles induce pyroptosis and cardiac hypertrophy via ROS/NLRP3/Caspase-1 pathway. Free Radic Biol Med 2022;182:171-81. [PMID: 35219847 DOI: 10.1016/j.freeradbiomed.2022.02.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
20 Zhou Y, Suo W, Zhang X, Lv J, Liu Z, Liu R. Roles and mechanisms of quercetin on cardiac arrhythmia: A review. Biomedicine & Pharmacotherapy 2022;153:113447. [DOI: 10.1016/j.biopha.2022.113447] [Reference Citation Analysis]